# Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)

> **NCT04149470** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 90 (estimated)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Omeprazole 20mg BID

## Key facts

- **NCT ID:** NCT04149470
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-10-07
- **Primary completion:** 2024-08
- **Final completion:** 2024-08
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04149470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04149470, "Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04149470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*